Dow Jones

38 852,86

-0,55%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

PULM

Pulmatrix (PULM)

Pulmatrix Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:PULM

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
17/05/2024	22h06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PULM	Pulmatrix Inc
15/05/2024	15h00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PULM	Pulmatrix Inc
10/05/2024	15h20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	15h21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	15h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PULM	Pulmatrix Inc
30/01/2023	22h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PULM	Pulmatrix Inc
16/05/2022	12h28	TipRanks	H.C. Wainwright Thinks Pulmatrix’s Stock is Going to Recover	NASDAQ:PULM	Pulmatrix Inc
29/04/2022	22h08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PULM	Pulmatrix Inc
19/04/2022	22h28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	23h23	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	15h21	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PULM	Pulmatrix Inc
14/02/2022	21h29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	15h10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	15h00	PR Newswire (US)	Pulmatrix Issues Letter to Stockholders	NASDAQ:PULM	Pulmatrix Inc
17/12/2021	12h14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PULM	Pulmatrix Inc
27/07/2021	16h00	PR Newswire (US)	Pulmatrix appoints Director Anand Varadan	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	22h09	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	14h15	TipRanks	Pulmatrix Will Regain Full Rights To PUR1800 After Termination Of Licensing Agreement; Shares Fall 16%	NASDAQ:PULM	Pulmatrix Inc
26/03/2021	21h01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PULM	Pulmatrix Inc
24/02/2021	16h23	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PULM	Pulmatrix Inc
23/02/2021	22h21	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:PULM	Pulmatrix Inc
14/08/2020	12h08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PULM	Pulmatrix Inc
07/08/2020	22h31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:PULM	Pulmatrix Inc
06/07/2020	12h31	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PULM	Pulmatrix Inc
25/06/2020	22h16	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:PULM	Pulmatrix Inc
23/04/2020	20h15	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:PULM	Pulmatrix Inc
18/09/2019	15h30	PR Newswire (US)	Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmo...	NASDAQ:PULM	Pulmatrix Inc
19/08/2019	15h25	PR Newswire (US)	Pulmatrix Receives US Patent Covering iSPERSE™ Formulations for Pulmazole Program	NASDAQ:PULM	Pulmatrix Inc
05/08/2019	15h00	PR Newswire (US)	Pulmatrix Reports Q2 2019 Results	NASDAQ:PULM	Pulmatrix Inc
25/07/2019	23h06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PULM	Pulmatrix Inc